Relative Bioavailability Study of CX2101A for the Treatment of COVID-19
Clinical trial NCT06864182 · COMPLETED
Trial details
- NCT number
- NCT06864182
- Sponsor
- Heronova Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-21
- Primary completion
- 2024-05-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.